Dublin, December 23, 2020 (GLOBE NEWSWIRE) – Added to the “Actinic (Solar) Keratosis Global Clinical Trials, H2, 2020” clinical trials ResearchAndMarkets.com’s offering.
“Global Review of Actinic (Solar) Keratosis Clinical Trials, H2, 2020” provides an overview of the state of Actinic (Solar) Keratosis clinical trials. This report provides mainline data relevant to the clinical trials of Actinic Keratosis (Solar).
The report includes an overview of test numbers and the average enrollment in major countries across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), stage, trial status, endpoint status and type of support. The report also provides explicit drugs for ongoing trials (based on the number of ongoing trials).
Scope
- The report paints a picture of the global clinical trial landscape
- The report provides high-level data related to the clinical trials by Region, Country (G7 & E7), Test Status, Test Level, Sponsorship Type and Completion Status
- The report reviews key companies involved and lists all tests (test title, Grade, and Status) that apply to the company.
- The report gives a reason for the non-performance of all unprepared tests (Completed, Suspended and Withdrawn)
- The Report provides record movements for the last five years
- Report providing the latest news for the past three months
Reasons to buy
- Helps formulate key business investment strategies
- Helps to identify prominent locations for clinical trials which saves time and cost
- Provides high-level analysis of the Global Clinical Trials Market that will help identify key business opportunities
- Supports understanding of country count testing and country-by-country record movements in the global therapeutic medicine market
- Assistance in defining clinical trial success rates by providing a comparative setting of completed and unfinished trials (completed, suspended or discontinued)
- Enables clinical trial evaluation of the brand at global, regional and country level
Key topics covered:
Report Management
- Cover of clinical trial report
Clinical trials by area
- Average clinical trials and enrollment by country
- Top five countries contributing to clinical trials in Asia-Pacific
- Top five countries contributing to clinical trials in Europe
- Leading countries contribute to clinical trials in North America
- Leading countries contribute to clinical trials in Middle East and Africa
- Leading countries contribute to clinical trials in central and southern America
- Clinical Trials with G7 Countries: A Share of Actinic Keratosis (Solar) to Dermatology Clinical Trials
- Level-based clinical trials in G7 countries
- Clinical trials in G7 countries according to trial standard
- Clinical Trials by E7 Countries: Share of Actinic Keratosis (Solar) to Dermatology Clinical Trials
- Level-based clinical trials in E7 countries
- Clinical trials in E7 countries according to trial standard
Stage-based clinical trials
- In phased progression tests
Clinical trials by trial standard
Clinical trials by completion status
- Subjects employed over time
Clinical trials by type of sponsor
- The famous sponsors
- Leading companies participating in clinical trials of Actinic (Solar) Keratosis Therapeutics
Obvious drugs
- Clinical Trial Profile Snapshots
Appendix
Companies mentioned
- LEO Foundation
- SA Galderma
- DermResearch Inc.
- Sun Sun Industries Ltd.
- Almirall SA
- Biofrontera AG
- Graceway Pharmaceuticals LLC
- Mylan NV
- TKL Research Inc.
- AbbVie Inc.
For more information about this clinical trial report visit https://www.researchandmarkets.com/r/23rqyo
Research and Markets also offers Custom Search services providing targeted, complete and unique search.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900